Picture of Regeneron Pharmaceuticals logo

REGN — Regeneron Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Refile: US FDA approves Regeneron's drug for generalized myasthenia gravis

REFILE-US FDA approves Regeneron's drug for generalized myasthenia gravis

Corrects day in paragraph 1 to Wednesday from Thursday

- The US Food and Drug Administration has approved Regeneron Pharmaceuticals' REGN.O drug to treat adults with generalized myasthenia gravis who test positive for anti-acetylcholine receptor antibodies, the company said on Wednesday.


(Reporting by Siddhi Mahatole in Bengaluru)

((siddhi.mahatole@thomsonreuters.com;))

Recent news on Regeneron Pharmaceuticals

See all news